IP Library Patent Application 17638827
Patent Application
App. No. 17/638,827

PROTEIN BASED CANNABIS COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/638,827
Abstract

Described herein are novel compositions comprising a cannabis component selected from the group consisting of: a cannabinoid, a flavonoid and a terpenoid; and a protein, selected from the group consisting of whey and a plant protein. According to an embodiment, the cannabis component is non-covalently bound to the whey or to the plant protein. The plant protein may be selected from the group consisting of: soy protein, pea protein, rice protein, hemp protein, and hops protein or other plant derived protein.

Claims (25)

1 . A composition comprising a cannabis component selected from the group consisting of: a cannabinoid, a flavonoid and a terpene; and a protein, selected from the group consisting of whey and a plant protein, wherein the cannabis component is non-covalently bound to the protein, and wherein the ratio of cannabis component to protein, by weight, is between 0.008 to 1 and 1.2 to 1.

2 . The composition according to claim 1 wherein the cannabis component is a cannabinoid.

3 . The composition according to claim 2 wherein the cannabinoid is THC or CBD.

4 . The composition according to claim 1 wherein the protein is whey proteins.

5 . The composition according to claim 1 wherein the protein is a plant protein.

6 . The composition according to claim 5 wherein the plant protein is selected from the group consisting of: soy proteins, pea proteins, rice proteins, hemp proteins, and hops proteins.

7 . (canceled)

8 . The composition according to claim 1 wherein the ratio of cannabis component to protein, by weight, is between 0.025 to 1 and 0.5 to 1.

9 . A composition comprising a cannabis component selected from the group consisting of: a cannabinoid, a flavonoid and a terpene; and a protein, selected from the group consisting of whey and a plant protein, wherein the cannabis component is non-covalently bound to the protein, and wherein the protein comprises a water-suspended fraction of the protein.

10 . The composition according to claim 1 , wherein the protein has an average molecular weight of between 1 and 100 kilodalton (kDa).

11 . The composition according to claim 10 wherein the protein has an average molecular weight of between 30-67 kDa.

12 . The composition according to claim 1 , wherein when the composition is in aqueous form at a cannabinoid concentration of 2 mg/ml and undergoes centrifugation at 3,300 RPM for 1 minute, the cannabis component remains suspended.

13 . (canceled)

14 . The composition according to claim 1 in the form of a candy, a chocolate, cookies, a sauce, a composition for sprinkling on food, a popsicle, a protein shake powder a beverage, a beer, a soft drink, alcoholic beverage, juice, gummy and a milkshake.

15 . The composition according to claim 1 in a dry solid form.

16 . The composition according to claim 1 and further comprising gelatin or pectin or agar-agar.

17 . A method for treatment of a disease comprising administering to a patient in need thereof a composition according to claim 1 in a pharmaceutical dosage form.

18 - 20 . (canceled)

21 . A method for manufacture of a composition comprising a cannabis component selected from the group consisting of: a cannabinoid, a flavonoid and a terpene; and a protein, selected from the group consisting of whey and a plant protein, wherein the cannabis component is non-covalently bound to the protein, comprising:

dissolving a cannabis component in an organic solvent to form an organic solution; and

combining the organic with an aqueous protein solution to form a crude cannabis-protein complex.

22 . The method according to claim 21 further comprising forming a complex between the cannabis component and the protein using nanoprecipitation or emulsification.

23 . The method according to claim 22 further comprising removing the residual organic solvent.

24 . The method according to claim 23 further comprising removing the residual water solvent.

25 - 27 . (canceled)

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2022
From: IZUN PHARMACEUTICALS CORPORATION
To: DAY THREE LABS MANUFACTURING INC.
Reel/Frame 059911/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2022
From: LECHT, SHIMON; GABAY, OLGA; LAHIANI HAFZADI, ADI; LEVINE, WILLIAM Z.
To: IZUN PHARMACEUTICALS CORP.
Reel/Frame 059110/0054 →